Selective delivery of cryogenic energy to intervertebral disc tissue and related methods of intradiscal hypothermia therapy

ABSTRACT

The present invention relates to devices and methods for altering the tissue in and around an intervertebral disc through localized hypothermia therapy to restore function of the disc and reduce pain. Hypothermia therapy is defined as the reduction of tissue temperature to below that of the equilibrium temperature. Target therapeutic temperatures and times are varied according to the desired treatment effect. Intended effects of hypothermia of the intervertebral disc include cellular disruption leading to cell death and or structural and chemical denaturation within the anulus fibrosus, nucleus pulposus, or nerve fibers, temporary or permanent deadening of the nerves within or surrounding the disc, induction of a healing response, angiogenesis, or accelerated degeneration and/or drying of the nucleus pulposus and/or anulus fibrosus. Various effects can be achieved by reaching different temperatures for differing periods of time or by the proximity of the hypothermia therapy device to the treatment target. Accordingly, it is an object of one or more the embodiments of the invention to provide hypothermic therapy to selected locations within an intervertebral disc utilizing a flexible and guidable cryogenic device.

RELATED APPLICATIONS

This application claims benefit to U.S. Provisional Application No.60/243,702 filed Oct. 30, 2000, the entire teachings of this applicationbeing incorporated herein by reference.

BACKGROUND OF THE INVENTION

1. Field of the Invention

The present invention relates generally to intervertebral discs andvertebrae and methods of hypothermia therapy applied thereto to relievepain and restore function.

2. Description of the Related Art

Low back pain afflicts more than 10 million people in the United Statesannually. It impacts the individual sufferer's life physically,emotionally and financially, restricting his or her activities and oftenleading to depression and absenteeism from work. As a nation, the UnitedStates spends more than $50 billion dollars in direct and indirectmedical expenses related to back pain, making it one of the leadinghealthcare expenditures overall.

The intervertebral disc consists of the anulus fibrosus, nucleuspulposus, and the endplates of the superior and inferior vertebralbodies. The anulus and endplates contain the nucleus as the disc ispressurized during normal activities. The posterior anulus is thinner incross-section than the anterior anulus and is correspondingly the sitemost frequently affected by injury.

Deterioration of the structure of the intervertebral disc is one of theleading causes of low back pain. The intervertebral disc is formed froma tough, outer anulus fibrosus surrounding a softer, gelatinous nucleuspulposus. The anular fibers attach securely to the endplates of thevertebral bodies superiorly and inferiorly, trapping the nucleus andcreating an isobaric environment. As load is applied through the spinalcolumn, pressure within the nucleus increases and is distributed acrossthe vertebral endplates and anulus. These structures flex and strainuntil the spinal load is equilibrated by intradiscal pressure allowingthe disc to act as a “shock absorber”. Lack of significant vascularityin the anulus and nucleus limits their healing potential.

Small nerve endings penetrate the outer anulus. As a person ages, rentsin the inner or central layers of the anulus can create focal regions ofhigh pressure in the outer anulus that mechanically stimulates thesenerve endings resulting in pain. There is also an increasing body ofevidence suggesting an inflammatory response in and around nerves withinthe anulus and within the epidural space behind the disc induced bychemicals within the nucleus, vertebral endplates, and vertebral bodies.Passage of these chemicals through the anulus can also occur because ofdamage to the anulus through physical trauma, progressive aging, ordegenerative disc disease. Under normal loading, portions of the nucleusor its degenerative byproducts may be forced into and through rents inthe anulus, such chemicals are thought to be transported into proximitywith these sensitive nerves resulting in inflammation and pain.

Therapeutic methods involving decreasing the temperature of the body ortissues thereof have a long history in medicine. Cold has been usedsuccessfully to bring about localized tissue necrosis, for cryoblationof tissue, as an anesthetic, and as a technique for inducingangiogenesis as a part of an overall healing response to the coldinjury. Cryotherapy can be defined as the therapeutic use of cold and isnot limited by any particular range of temperatures. Cryosurgery orcryocautery is usually more narrowly defined not merely as the use ofcold in surgical applications but as the technique of exposing tissue toextreme cold in order to produce well demarcated areas of cell injuryand destruction. Cryosurgical temperatures are typically below −20° C.On the other hand, hypothermia therapy involves a technique of loweringbody or tissues thereof below body temperature, usually between 26°C.-32.5° C. Cryosurgery is distinguishable from the other two methods inthat tissue is cut or ablated or otherwise destroyed with precisionwhereas cyrotherapy and hypothermia therapy techniques utilize cold orextreme cold to improve the health of tissue through stimulation.Accordingly, for purposes of this disclosure, hypothermia therapyincludes cryotherapy or the therapeutic use of cold and extremely coldtemperatures well below normal body temperature. Also, to the extentthat related instrumentation such as hypothermia needles, cryogeniccatheters, and cryoprobes (flexible or rigid) can be used to applycryoenergy or cool tissue to a broad range of temperatures below normalbody temperature, use of a specific type of instrument in a method ofthe invention disclosed herein does not necessarily imply a certainrange of therapeutic temperatures. For instance, cryoprobes andcryocatheters may be used interchangeably according to variousembodiments of the present invention.

SUMMARY OF THE INVENTION

Various embodiments of the present invention relate to devices andmethods for treating the tissue in and around the intervertebral discthrough localized hypothermia therapy to reduce pain or restore functionin the disc and surrounding tissue. Hypothermia therapy is defined asthe reduction of tissue temperature to below that of the equilibriumtemperature. Target therapeutic temperature ranges from about −272°C.-37° C. for at least one period of up to about an hour depending uponthe desired treatment effect.

According to various methods of the invention, hypothermia therapy ofthe intervertebral disc and adjacent vertebral bodies may be used toreduce painful pathological states of the spine. Various embodiments ofthe disclosed method may involve exposure of tissues including theanulus fibrosus, nucleus pulposus, and adjacent vertebral bodiesincluding their respective nerve fibers to a range of low temperaturesover a period of time. Depending on the temperatures and exposure time,this can lead to structural or chemical denaturation of tissue includingselective cell death and cryoblation. The therapy may also involvetemporary or permanent deadening of the nerves within or surrounding thedisc. Also, hypothermia therapy may be used for the induction of ahealing response, angiogenesis, or accelerated degeneration and/ordrying of the nucleus pulposus and/or anulus fibrosus. Various effectscan be achieved by reaching different temperatures for differing periodsof time or by the proximity of the hypothermia therapy device to thetreatment target. Accordingly, it is an object of one or more theembodiments of the invention to provide hypothermia therapy to selectedlocations within an intervertebral disc.

In one or more embodiments of the invention, the therapy may bedelivered via a flexible, elongated catheter, by a flexible or rigidprobe, or by a cooling element extending along at least a portion of alength of an articulated segment of a therapy delivery probe. Thedevices may be delivered through an open surgical approach or viapercutaneous approaches to the intervertebral disc and surroundingstructures.

Various embodiments of the invention may be practiced with a cryoprobehaving a blunt tip or a retractable blunt or curved tip surface capableof deflecting off of the anular surface as the probe is advanced intothe disc or along the surface of an anular lamella. Such a tip may alsobe used to deflect off of a vertebral endplate or the interior surfaceof a vertebral body.

The method of applying hypothermia to the disc may be accompanied byconcurrent measurement of the local tissue temperature. This may be donethrough the use of thermocouples in the probe itself or by the use ofsecondary devices positioned within the tissues in or around the disccapable of temperature measurement. The region of therapy may also bemonitored non-invasively through the use of ultrasound or comparableimaging technique capable of identifying the formation and extent of icewithin living tissue. This technique is commonly referred to ascryomapping.

BRIEF DESCRIPTION OF THE DRAWINGS

FIGS. 1A and 1B depict transverse and sagittal sections of theintervertebral disc and surrounding bony anatomy.

FIG. 2 is a transverse view of a disc and a cryoprobe device insertedwithin. The distal cutting tip is positioned within the nucleus of thedisc.

FIG. 3 is a transverse view of a disc and depicts the use of a separatetemperature-sensing probe as part of a method of performing hypothermiatherapy on the intervertebral disc.

FIG. 4 is a transverse view of a disc and depicts the use of anexpandable hypothermia balloon as part of the method of the presentinvention.

FIG. 5 is a transverse view of a disc and depicts a cryoprobe with anarticulated or flexible region towards the distal end. The flexibleregion is positioned toward the posterior aspect of the disc to treatthe posterior anulus.

FIG. 6 is transverse view of a disc and depicts a cryoprobe with anarticulated or flexible region and is positioned within the layers ofthe posterior anulus.

FIG. 7 is a transverse view of a disc and depicts a method of advancinga blunt tipped cryoprobe along the interior of the anulus enabling thethermally transmissive region to be positioned adjacent the tissue ofthe posterior anulus.

FIG. 8 is a transverse view of disc and depicts a hypothermia needleinserted within the posterior anulus from a transpsoas approach.

FIG. 9 is a transverse view of the disc and depicts a hypothermia needleinserted within the lateral anulus from a posterio-lateral approach.

FIG. 10 is a side view of the cryoprobe inserted within an inferiorvertebral body.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT

The embodiments and methods described below are given as illustrativeexamples of those that fall within the scope of the present invention,but are not intended to limit that scope. These devices and methods maybe the sole devices and procedures performed on the intervertebral discat the time of therapy or may accompany other procedures such asdiscectomy, laminectomy, fusion, decortication of the endplates, etc.

Various embodiments of the present invention relate to devices andmethods for altering the tissue in and around the intervertebral discthrough localized hypothermia therapy. According to several aspects ofthe invention, various cryogenic or hypothermic instrumentation aredesigned to deliver cryogenic energy within the nucleus, anulus,endplates, the epidural or dural space, or within the vertebral bodies.Hypothermia therapy and cryotherapy as used in this disclosure shall bedefined as the reduction of tissue temperature to below that of theequilibrium temperature. Target therapeutic temperatures can range fromabout −272° C.-37° C. and exposure times can range from seconds toseveral hours depending upon the desired treatment effect. Further, thetherapy may take place during one procedure or during timely spacedintervals. Multiple treatments and/or use of multiple therapeutictemperatures may be used according to various embodiments of theinvention. A typical nitrous oxide cryotherapy instrument reachestemperatures around −90° C. and can cauterize and destroy tissue withina few minutes of contact and may be done in cycles, e.g. for a two cycletreatment: freeze, thaw; freeze, thaw; finish. Apoptosis, or programmedcell death, can occur from the exposure of tissues to temperaturesaround 0° C. for an extended period. Here, cell death is not immediateand occurs only after a series of reactions induced by the treatment. Tocontrol pain and prevent bleeding higher temperatures above about −20°C. are preferably used. For example, mild hypothermia therapytemperatures are typically in the range of about 32° C.-35° C. Thesetemperatures may be achieved gradually at a rate of about 0.5-1.0°C./hr.

Intended effects of hypothermia of the intervertebral disc and adjacentvertebral bodies according to one or more embodiments of the inventioninclude tissue disruption leading structural denaturation, chemicaldenaturation, or cell death within the anulus fibrosus, nucleuspulposus, or nerve fibers, temporary deadening of the nerves within orsurrounding the disc, induction of a healing response, angiogenesis, oraccelerated degeneration and/or drying of the nucleus pulposus and/oranulus fibrosus. Also, it should be noted that some mechanisms of actionare not fully understood involving the use of hypothermia therapy butclinical usage nonetheless proves the value of these methods in relieffrom back pain and restoration of function to the intervertebral disc.

According to the invention, various physiological effects may arise frommere cooling of the tissue just below body temperature to exposing thetissue to extreme cooling sufficient for cryoblation. Accordingly,inventive methods include exposure of vertebral disc and/or nucleartissue to different temperatures for differing periods of time and byvarying the proximity of the hypothermia therapy device to the treatmenttarget. Also, other variables affecting the treatment such as thephysical properties of the tissue, e.g. anular thickness and degree ofherniation, depth of insertion within a tissue, and the properties of agiven hypothermia device, e.g. thermal conductivity and surface area,vary widely but are readily determined by one skilled in the art throughexperimentation and therapeutic methods may be adjusted accordingly.

Hypothermia probes or cryogenic catheters have evolved in the art suchthat linear elongated lesions may be ablated using a steerable flexibletipped instrument. Such a device is described in U.S. Pat. No.5,899,898, the teachings of which are herein incorporated by reference.Prior to such advances, only spot or regional cooling and ablation werepracticed. Such probes or catheters may be sized small enough to fitthrough blood vessels or larger to deliver more power and present moresurface area depending on the application. Also incorporated byreference is the flexible cryoprobe disclosed in U.S. Pat. No.5,108,390. These two references also disclose external refrigerationdevices for providing cryogenic energy which are suitable for use withthe cryoprobes and hypothermia needles of the present invention.

The instrumentation and methods comprising several embodiments of thecurrent invention may be utilized in a variety of surgical approaches inorder to selectively deliver cryogenic energy to the tissues within andproximate to an intervertebral disc. An anterior surgical approachprovides direct access to intervertebral discs but the invasiveness tothe abdominal organs and blood vessels is substantial. A posteriorlateral approach is less invasive but provides limited and obliqueaccess to the disc and its interior. A transpsoas approach, i.e. acrossthe psoas muscle is also possible. A laminectomy may be useful inincreasing access to the targeted tissue but is usually not necessary ifa flexible cryoprobe is used. Transpedicular and presacral ortranssacral (wherein the device enters the body proximate to the sacrumand is directed cephalically toward the spine) approaches are alsopossible. According to a preferred embodiment of the inventive method, ahypothermia device, be it a hypothermia needle, a cryoprobe, acryocatheter, used with or without a delivery cannula, may be insertedthrough or within the anulus according to any one of the surgicalapproach methods describe herein or as practised by surgeons. The devicecan be delivered through an iatrogenic hole in the anulus or through anexisting defect.

The device can also be inserted within or partially through aniatrogenic hole in an adjacent vertebral body to treat the tissueswithin the body, especially the endplate, or within an adjacent disc.

FIG. 2 depicts one embodiment of the present invention and correspondingmethod. A transverse section of the disc including the anulus 1 andnucleus 2 with the bony anatomy removed is shown to highlight oneembodiment of the present invention. The cryoprobe 30 depicted in thisfigure comprises a distal cutting tip 40, a proximal 50 and distalthermocouple 55, and a thermally-transmissive hypothermia region 60 influid or gas connection with an external refrigeration device (notshown). The thermally transmissive region 60 may be active during theentire procedure or preferably activated when advancement of thecryoprobe 30 by the surgeon causes it to be positioned adjacent to orwithin the targeted tissue. According to one preferred method, thecryoprobe is inserted into the nucleus through the posterior lateralanulus. Once positioned in the desired treatment site, a coolant means70 such as refrigerated liquid, an expanding gas, or a vaporizing liquidis driven toward the thermal-transmissive region 60 of the cryoprobe 30through interior lumens within the cryoprobe 30. Exemplary liquidscomprising the coolant means 70 include HCF's, CFC's,chlorodifluoromethane, polydimethylsiloxane, ethyl alcohol, liquidnitrogen, and pentafluoroethane. Exemplary gasses comprising the coolantmeans 70 include nitrous oxide and carbon dioxide. Also, in addition tothe circulation of cryogenic fluids from a reservoir to the thermallytransmissive hypothermia region 60 of the device, the region 60 itselfcan be designed to be a site of a controlled endothermic reactionwherein the resultant cooling is transferred through its thermallytransmissive surface to the target tissue.

Decreases in tissue temperature surrounding the cryoprobe 30 can bemeasured by the proximal and distal thermocouples. Thermocouples 50, 55may be positioned proximate critical treatment landmarks to minimizespread of the therapy to non-target regions. The treatment temperaturedetected at the thermocouples 50, 55 may be controlled through afeedback loop (not shown). This control may be used to generate adesired time and temperature profile that may be advantageous inachieving a desired therapeutic affect. Such feedback may also help theuser know when a desired temperature has been achieved. Other cryoprobeswith thermocouples may be positioned in various locations to affordgreater information about the temperature within and surrounding thedisc and increase treatment efficiency.

The specific embodiment of the cryoprobe 30 depicted in FIG. 2 is givenfor illustrative purposes and is not intended to limit the scope of thepresent invention. The cryoprobe 30 may have only one or a multitude ofthermocouples positioned at various locations along the instrumentslength and/or within the thermally transmissive hypothermia region 60.The thermocouples are only one of a number of possible temperaturesensing devices that include, but are not limited to thermistors.Multiple thermocouples or thermistors may be used at strategic locationsalong the probe's 30 length. The hypothermia region 60 may be locatedover a contiguous length of cryoprobe 30 as shown or may be in amultitude of locations. The hypothermia region 60 may surround thecircumference of the needle or may be along only one side. Also,surfaces of the cryoprobe 30 that do not contain thermally transmissivehypothermia regions 60 can be insulated so as to not conduct or absorbheat. Such an embodiment is preferable since it affords greater controlof the tissues affected by the treatment. For example, the probe 30 maybe thermally insulated on all but a single face or side such that whenhypothermia therapy applied to a targeted area of a lamella in theposterior anulus, medial tissue towards the center of the disc such asinner lamella and the nucleus pulposus are not exposed to excesscooling.

Multiple cryoprobes may be used during a single procedure to help shapeor reach the region of tissue to be treated. Other devices, such astrocars, wires or cannulae may be used to help gain access to the discto allow insertion of the needle. In this case, the cutting tip 40depicted in the embodiment of FIG. 2 is not necessary and may bereplaced by a blunt dissection tip 45. Moreover, for certainapplications, a blunt tip 45 may be preferable for deflection off of thesurface of the interior of the disc, i.e. the walls of the anulus andthe endplates, as the device is advanced.

FIG. 3 shows another embodiment of the cryoprobe 30 being used incombination with a separate temperature-monitoring probe 90. Thetemperature probe 90 is depicted with a cutting tip 40 and athermocouple 50 and has been inserted from the contra-lateral side ofthe anulus into the nucleus. This probe may be positioned within or atthe boundary of the targeted tissue to monitor tissue temperaturesduring therapy. This temperature information may be used as part of afeedback loop as discussed above.

FIG. 4 depicts an expandable thermally transmissive hypothermia regionor balloon 100 on the distal end of a hypothermia catheter 110. Thehypothermia balloon 100 is inflated with a low temperature gas or fluidonce positioned within the desired target tissues. If a fluid isemployed, it should have a freezing temperature below the desiredtherapeutic temperature. Such fluids include, but are not limited to,alcohol or saline with a high salt content. The balloon may be in fluidconnection with any of a variety of suitable refrigeration devicesthrough interior lumens of the hypothermia catheter. The balloon 100 maybe shaped or reinforced to preferentially expand in desired directionssuch as parallel to the vertebral endplates. The hypothermia catheter110 is depicted with a proximal thermocouple 50 to aid in achievingtherapy at the desired treatment temperature. The balloon 100 is shownwithin the nucleus or nuclear space, but may also be within the anulusor within a vertebral body surrounding the disc.

The catheter 110 may be wholly or partially flexible along all or aportion of its length. It may be inserted through the lumen of cannula80 or advanced without support through an existing incision or defect inthe anulus from any of the surgical approaches described above.

FIG. 5 depicts the cryoprobe 30 and a method for selectively treatingtissue along the lateral and posterior anulus. This position is alsoeffective for treating tissues within the posterior anulus i.e.,intra-anularly or between lamella of the anulus. In this embodiment, thecryoprobe 30 of the present invention is flexible and articulated. Itshould be understood that no limitation is implied by the use of theword “cryoprobe”. Other instruments, including a cryocatheter, usedaccording to these methods could be designed and used in the identicalmanner. The probe 30 may be wholly or partially flexible or rigid alongall or a portion of its length. Also, the probe 30 may exhibit differentstiffnesses in different planes such that travel in a single plane isencouraged and travel or flex in planes orthogonal to that plane are notpossible. The probe 30 can be biased or preshaped to form a curve ofsimilar radius of the subject intervertebral disc. Such curvatures canbe advantageous in directing the probe along the surface of an anularlamella and toward target tissues.

The probe 30 may be inserted through a straight cannula 80 into the discand then advanced out of the cannula 80 to take on its pre-formed shape.Alternatively, the probe can be articulated to allow control of itsshape and orientation by the user from outside of the disc through asystem of guide wires and joints running along the length of the probe30. In addition, the probe 30 may be passed through the interior of acurved, bent or articulated delivery cannula 80 and delivered along thesurface of the anulus. The cannula may be selectively insulated alongall or a portion of its length to help shape the treated region oftissue.

FIG. 6 depicts an alternative method of treating tissues within theposterior anulus of the disc. The flexible cryoprobe 30 has beenadvanced between lamellae of the anulus along the posterior anulus. Thisallows for precise localization of the intended hypothermia treatment tothis tissue. FIG. 7 depicts another method of treating tissues withinthe posterior anulus of the disc. The delivery cannula 80 is insertedthrough an iatrogenic hole or pathological hole in the posterio-lateralanulus. The probe 30 is then advanced out of the cannula 80 through thenucleus pulposus and then deflected off of the anulus and furtheradvanced along the anular surface until it reaches the target locationalong the opposites side of the posterior anulus. According to thismethod, the tissue of the anterior anulus may also be treated simply bynot advancing the probe 30 within the disc so far as to cause it to arcaround or deflect off of the anular surface and activating the thermallytransmissive hypothermia region 60 located near the distal end of theprobe 30 when it contacts anular tissue along the anterior anulus. Inthis application, a blunt or curved tip 45 is useful for deflecting ofthe anular surface. Also, a slight curvature or bias of the probe aidsin the control and predictability of the path traveled by the probe.

Instrumentation smaller and less invasive than standard cryoprobes, suchas hypothermia needles (which utilize the same technology as thecryoprobes in transferring cryogenic energy but are generally stifferand of a smaller diameter) may be used and inserted at various pointsand depths within the anulus. This method is shown in FIG. 8 and depictsa hypothermia needle 130 treating tissue in the posterior anulus from atranspsoas approach. FIG. 9 is a transverse view of the disc and depictsthe hypothermia needle 130 treating tissue within the lateral andanterior anulus from a posterio-lateral approach.

FIG. 10 depicts a method wherein a hypothermia device is used to treat avertebral body and especially its endplate which defines the surface indirect communication with the adjacent disc. Vertebral endplates containsensitive nerves and are often a significant source of back pain. Herean iatrogenic access hole is drilled into the bone to allow insertion ofthe cryoprobe 30 within. Alternatively, the cryoprobe 30 may simplycontact the bone surface. Hypothermia therapy applied to vertebralbodies is particularly advantageous in reducing pain, stimulating ahealing response in the marrow and bone tissue, and destroying tumorsand growths. Alternatively, the endplates may be treated from within thedisc by advancing the cryoprobe into the nucleus and presenting thethermally transmissive region 60 vertically such that it is adjacent tothe targeted endplate tissue.

In addition to tactile feedback from the device it may be preferable tomonitor the percutaneous travel of the device in situ. MRI, ultrasound,and other imaging techniques may be utilized to monitor the location ofthe hypothermia therapy device and hypothermic zone itself as itexpands. This tracking of the cooling zone is known as cryomapping andis well known in the art. If real time viewing is employed, this methodcan be used to monitor the actual physiological progress rather thanrelying on measurements of exposure time and approximations of varioustissue chemical and physical properties and corresponding responses tohypothermia therapy.

The foregoing description of preferred embodiments of the invention hasbeen presented for purposes of illustration and description. It is notintended to be exhaustive or to limit the invention to the precise formsdisclosed. Many modifications and variations will be apparent topractitioners skilled in the art. It is intended that the scope of theinvention be defined by the following claims and their equivalents.

1. A method of delivering cryogenic energy to a selected location alongan anular surface of an intervertebral disc comprising: inserting acryoprobe into the disc through an opening within said disc, whereinsaid cryoprobe has a thermally transmissive region for transferringcryogenic energy to the selected location; advancing said cryoprobewithin said disc; arcing said cryoprobe around a portion of an interioraspect of an anular lamella defining the anular surface; and deliveringthe cryogenic energy to said selected location.
 2. The method of claim1, wherein said cryoprobe is blunt-tipped and flexible.
 3. The method ofclaim 1, wherein said opening is an iatrogenic hole.
 4. The method ofclaim 1, wherein said thermally transmissive region is located at ornear the distal tip of said cryoprobe.
 5. The method of claim 1, furthercomprising delivering a coolant to the thermally transmissive region. 6.The method of claim 5, wherein said coolant is selected from the groupconsisting of: a refrigerated liquid, an expanding gas, and a vaporizingliquid.
 7. The method of claim 5, wherein said coolant is selected fromthe group consisting of: HCF's, CFC's, chlorodifluoromethane,polydimethylsiloxane, ethyl alcohol, liquid nitrogen, pentafluoroethane,nitrous oxide and carbon dioxide.
 8. A method of hypothermicallytreating selected tissue of an intervertebral disc anulus comprising:inserting a needle into the anulus through an opening, wherein saidneedle has a thermally transmissive region in communication with anexternal refrigeration device for providing cryogenic energy, advancingthe needle between anular lamellae to a location adjacent the selectedtissue along the circumference defined by the lamellae; and applyingcryogenic energy to the selected tissue.
 9. The method of claim 8,wherein said needle is an elongated hypothermia needle with a distalsharpened tip.
 10. The method of claim 8, wherein said opening is aniatrogenic hole.
 11. The method of claim 8, wherein said opening isformed by the advancement of said tip.
 12. The method of claim 8,further comprising delivering a coolant to the thermally transmissiveregion.
 13. The method of claim 12, wherein said coolant is selectedfrom the group consisting of: a refrigerated liquid, an expanding gas,and a vaporizing liquid.
 14. The method of claim 12, wherein saidcoolant is selected from the group consisting of: HCF's, CFC's,chlorodifluoromethane, polydimethylsiloxane, ethyl alcohol, liquidnitrogen, pentafluoroethane, nitrous oxide and carbon dioxide.
 15. Amethod of hypothermically treating selected tissue of a vertebral bodycomprising: inserting a hypothermia instrument into the vertebral bodythough an opening, wherein said instrument has a thermally transmissiveregion in communication with an external refrigeration device forproviding a therapeutic temperature; advancing the thermallytransmissive region within the vertebral body; and activating saidexternal refrigeration device, thereby cooling the thermallytransmissive region and adjacent vertebral body tissue.
 16. The methodof claim 15, wherein said instrument is a hypothermia needle with adistal sharpened tip or a blunt-tipped flexible cryoprobe.
 17. Themethod of claim 15, wherein said opening is an iatrogenic hole.
 18. Themethod of claim 15, wherein said opening is created by drilling a holeinto the bony section of the vertebral body.
 19. The method of claim 15,wherein said thermally transmissive region is cooled to a temperature inthe range of 0° F. to 98.5° F.
 20. The method of claim 15, wherein saidthermally transmissive region is cooled for one or more time periods inthe range of 1 minute to 60 minutes.
 21. The method of claim 15, furthercomprising delivering a coolant to the thermally transmissive region.22. The method of claim 21, wherein said coolant is selected from thegroup consisting of: a refrigerated liquid, an expanding gas, and avaporizing liquid.
 23. The method of claim 21, wherein said coolant isselected from the group consisting of: HCF's, CFC's,chlorodifluoromethane, polydimethylsiloxane, ethyl alcohol, liquidnitrogen, pentafluoroethane, nitrous oxide and carbon dioxide.
 24. Amethod of hypothermically treating selected tissue of a vertebral bodycomprising: inserting a cryoprobe into the vertebral body through anopening in said body, wherein said probe has a thermally transmissiveregion for presenting hypothermic temperatures located proximate to thedistal tip; advancing the cryoprobe within said body; arcing saidcryoprobe around an interior of the body; and delivering the cryogenicenergy to said selected tissue.
 25. The method of claim 24, wherein saidcryoprobe is blunt-tipped and flexible.
 26. The method of claim 24,wherein said opening is an iatrogenic hole.
 27. The method of claim 24,wherein the thermally transmissive region is placed adjacent to thetissue within the body defining the superior endplate of a disc belowsaid body.
 28. The method of claim 24, wherein the thermallytransmissive region is placed adjacent to the tissue within the bodydefining the inferior endplate of a disc above said body.
 29. The methodof claim 24, further comprising delivering a coolant to the thermallytransmissive region.
 30. The method of claim 29, wherein said coolant isselected from the group consisting of: a refrigerated liquid, anexpanding gas, and a vaporizing liquid.
 31. The method of claim 29,wherein said coolant is selected from the group consisting of: HCF's,CFC's, chlorodifluoromethane, polydimethylsiloxane, ethyl alcohol,liquid nitrogen, pentafluoroethane, nitrous oxide and carbon dioxide.32. A method of treating spinal pain by delivering cryogenic energy to aselected location on intervertebral disc comprising: inserting acryoprobe into the disc through an opening within said disc, whereinsaid cryoprobe has a thermally transmissive region for transferringcryogenic energy to the selected location; advancing said cryoprobewithin said disc; arcing said cryoprobe around a portion of said disc;and delivering the cryogenic energy to said selected location.
 33. Themethod of claim 32, wherein said cryoprobe is blunt-tipped and flexible.34. The method of claim 32, wherein said opening is an iatrogenic hole.35. The method of claim 32, wherein said thermally transmissive regionis located at or near the distal tip of said cryoprobe.
 36. The methodof claim 32, further comprising delivering a coolant to the thermallytransmissive region.
 37. The method of claim 36, wherein said coolant isselected from the group consisting of: a refrigerated liquid, anexpanding gas, and a vaporizing liquid.
 38. The method of claim 36,wherein said coolant is selected from the group consisting of: HCF's,CFC's, chlorodifluoromethane, polydimethylsiloxane, ethyl alcohol,liquid nitrogen, pentafluoroethane, nitrous oxide and carbon dioxide.39. A method of delivering cryogenic energy within a vertebral bodycomprising: forming a hole within the vertebral body; inserting acryoprobe into said body, wherein said cryoprobe has a distal tip and athermally transmissive region located proximate to said tip; activatingsaid thermally transmissive region; and delivering cryogenic energy forone or more time periods in the range of 1 minute to 60 minutes.